CCL Home Page
Up Directory CCL 09.06.04 CHI's Structure-Based Drug Design
From: chemistry-request at ccl.net
To: chemistry-request at ccl.net
Date: Wed Feb 4 14:56:39 2009
Subject: 09.06.04 CHI's Structure-Based Drug Design
Dates: June 4-5,2009
Venue: Royal Sonesta Hotel, Cambridge, Massachusetts USA

Topics of discussion include:
- Target Structure-Guided Drug Discovery
- Feeding SBDD with Biochemical and Biophysical Information
- Ligand-Based Predictions Applied to Drug Design
- SBDD and Computational Chemistry Methods: A Marriage of Innovation
- SBDD of Pharmacological Chaperons

Distinguished Faculty:
Alex Aronov, Ph.D., Vertex Pharmaceuticals, Inc.

Xavier Barril, Ph.D. , ICREA Research Universitat de Barcelona

Alex Burgin, Ph.D., deCODE Biostructures

Miles Congreve, Ph.D., Heptares Therapeutics Ltd.

José Duca, Ph.D., Schering Plough Research Institute

Stefan Geschwindner, Ph.D., AstraZeneca R&D Mölndal

Ajay N. Jain, Ph.D., University of California, San Francisco

Paul Labute, Ph.D., Computing Group (CCG)

Dr. Richard J. Law, Evotec AG

Brian B. Masek, Ph.D., Tripos International

Mark Murcko, Ph.D., Vertex Pharmaceuticals, Inc.

Sander Nabuurs, Ph.D., Radboud University Nijmegen

Enrico O. Purisima, Ph.D., National Research Council of Canada

Dagmar Ringe, Ph.D., Brandeis University

Suo-Bao Rong, Ph.D., Pfizer Global R&D

Tomi Sawyer, Ph.D., AILERON Therapeutics; Editor-in-Chief, Chemical Biology & Drug Design

Andrew D. Scott, Ph.D., Pfizer Global Research and Development

Suresh Singh, Ph.D., Vitae Pharmaceuticals

Raymond C. Stevens, Scripps Research Institute

Gergely Toth, Ph.D., Elan Pharmaceuticals

Marcel Verdonk, Ph.D., Astex Therapeutics, Ltd.

Markus Wagener, Ph.D., Schering-Plough Research Institute

W. Patrick Walters, Ph.D., Vertex Pharmaceuticals, Inc.

Plus! Pre-Conference Workshop, Wednesday, June 3
Designing Kinase Inhibitors*

Topics Discussed:
- Challenges of Crystal Structures
- X-Ray Crystallography
- Target Immobilized NMR Screening
*Separate registration is required.

Arrive early to attend...
Protein Kinase Targets
June 1-3
www.healthtech.com/KIN/overview.aspx

Interested in Sponsorships and Exhibit Opportunities?
Contact:
Katelin Fitzgerald
Manager, Business Development
Tel: 781-972-5458
E-mail: kfitzgerald(0)healthtech.com

Special Pricing is Available to Attend Both the Structure-Based Drug Design and Protein Kinase Conferences.

Learn more and register at www.healthtech.com/SBD/overview.aspx

Otherwise, call CHI at 781-972-5400.
NOTE THAT E-MAIL ADDRESSES HAVE BEEN MODIFIED!!!
All @ signs were changed to (0) to fight spam. Before you send e-mail, you need to change (0) to @
For example: change joe(0)big123comp.com to joe@big123comp.com
Please let colleagues know about conference listingts at Computational Chemistry List Conference Page at http://www.ccl.net/chemistry/a/conferences/.

Please help: If you find this conference list useful but you noticed some conference missing, please consider including it here by using the Conference Submission Page. It is free but your support is welcome. You will help others!!!

Modified: Wed Feb 4 19:56:39 2009 GMT
Page accessed 3374 times since Wed Feb 4 19:55:01 2009 GMT

Please help maintain CCL: If you found that your conference is listed here, please consider supporting CCL as a Supporting Member or use other Paid Services of CCL to ensure the continuation of this useful service. We cannot do it without your help.